| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX003 (ip) | median survival time | saline | 0.97 mg/kg/injection | 182.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 1.62 mg/kg/injection | 208.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 2.7 mg/kg/injection | 295.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 4.5 mg/kg/injection | 391.0 | Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 7.5 mg/kg/injection | 230.0 | Antitumor endpoint evaluated on day 45; 07/07 animals surviving on day 5 |